Fact CheckerSign in

NCT07827378Not yet recruiting

Early Discharge After Colorectal Surgery

RECUPERA-C Study: Protocol: Personalised and Controlled Rapid Recovery After Colorectal Surgery

Source: ClinicalTrials.gov · Last updated 18 Sept 2026

Brief summary (registry, in English)

RECUPERA-C is a prospective observational pilot study evaluating the feasibility and safety of an early discharge strategy within 48 hours after minimally invasive colorectal surgery. The study will assess whether patients can meet predefined clinical and functional discharge criteria, and will identify factors that may prevent early discharge. C-reactive protein and neutrophil-to-lymphocyte ratio will also be evaluated as exploratory markers of postoperative complications.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
97 (estimated)
First submitted
14 Sept 2026
Start date
1 Sept 2026
Primary completion date
1 Sept 2026
Lead sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
NCT number
NCT07827378

What you commit to

  • Study type: Observational
  • Planned participants: 97
  • From 1 Sept 2026 to the primary completion date, 1 Sept 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Emergency surgery.

Other illness

  • Functional dependence or significant cognitive impairment.

Other

  • Significant intraoperative complications.
  • Major multivisceral resections.
  • New ostomy creation.
  • Decompensation of major comorbidities.
  • Anticipated need for postoperative admission to an intensive care unit.
  • Social circumstances that may make early discharge unsafe.

Who the study is looking for

  • Age ≥18 years.
  • Elective major colorectal surgery for benign or malignant disease.
  • Minimally invasive approach (laparoscopic or robotic).
  • ASA physical status I-III.
  • Functional independence in basic activities of daily living.
  • Adequate home support and the ability to access and return to the hospital if required.
  • Adequate understanding of the perioperative plan.
  • Written informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.